Cigna Group $CI Shares Bought by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Cigna Group by 19.6%, now holding 109,569 shares valued at approximately $35 million.
• Cigna Group's stock has shown a 1.2% decline, with shares trading around $290.16, while the company recently reported quarterly earnings exceeding expectations.
• Analysts have set new price targets for Cigna Group, with Barclays raising its target to $383.00 and Deutsche Bank setting it at $415.00, reflecting positive sentiment about the stock.

Wealth Enhancement Advisory Services LLC increased its position in Cigna Group (NYSE:CI - Free Report) by 19.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,569 shares of the health services provider's stock after buying an additional 17,960 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Cigna Group were worth $35,035,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of CI. Brighton Jones LLC raised its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after buying an additional 318 shares during the last quarter. Focus Partners Advisor Solutions LLC grew its holdings in Cigna Group by 15.7% in the fourth quarter. Focus Partners Advisor Solutions LLC now owns 2,940 shares of the health services provider's stock valued at $812,000 after purchasing an additional 399 shares during the period. City National Bank of Florida MSD purchased a new stake in Cigna Group in the fourth quarter valued at approximately $208,000. Vise Technologies Inc. grew its holdings in Cigna Group by 66.3% in the fourth quarter. Vise Technologies Inc. now owns 4,019 shares of the health services provider's stock valued at $1,110,000 after purchasing an additional 1,603 shares during the period. Finally, Stonebridge Financial Planning Group LLC grew its holdings in Cigna Group by 5.1% in the fourth quarter. Stonebridge Financial Planning Group LLC now owns 987 shares of the health services provider's stock valued at $273,000 after purchasing an additional 48 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.70% of the stock is owned by company insiders.

Cigna Group Stock Down 0.3%

Shares of CI stock traded down $0.91 on Monday, hitting $289.45. The stock had a trading volume of 665,922 shares, compared to its average volume of 1,801,229. The firm has a market capitalization of $77.26 billion, a price-to-earnings ratio of 15.81, a P/E/G ratio of 0.85 and a beta of 0.48. The stock's 50 day moving average is $293.99 and its 200-day moving average is $311.53. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Thursday, September 4th. Cigna Group's dividend payout ratio is 32.97%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CI shares. Wells Fargo & Company lowered their target price on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a report on Monday, June 23rd. Royal Bank Of Canada restated an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a report on Thursday, June 26th. Cantor Fitzgerald reiterated an "overweight" rating and set a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Finally, Guggenheim reiterated a "buy" rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $371.81.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.